Skip to main content
Log in

AHF calls for lower AIDS drug prices as government caps funding

  • Media release
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Notes

  1. the manufacturer of Stribild [elvitegravir/emtricitabine/tenofovir disoproxil fumarate/cobicistat], the most expensive HIV combination therapy at a cost of $28 500 per patient per year

Reference

  • AIDS Healthcare Foundation. AHF: Congress Puts Foot Down on Funding High-Priced AIDS Drugs. Media Release : 27 Mar 2013. Available from: URL: http://www.aidshealth.org

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

AHF calls for lower AIDS drug prices as government caps funding. PharmacoEcon Outcomes News 675, 11 (2013). https://doi.org/10.1007/s40274-013-0301-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-013-0301-1

Navigation